Skip to main content

Malignant Eccrine Spiradenoma

  • Chapter
  • First Online:
  • 1484 Accesses

Abstract

Malignant eccrine spiradenoma (MES) is an extremely rare aggressive tumor, firstly reported in 1972 by Dabska that can occur de novo or more commonly arise on a preexisting often long-standing eccrine spiradenoma. The latency period before malignant transformation ranges from 6 months to 70 years. To date, about 102 cases have been reported, mostly as single case report.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Bibliography

  • Andreoli MT, Itani KM. Malignant eccrine spiradenoma: a meta-analysis of reported cases. Am J Surg. 2011;201:695–9.

    Article  PubMed  Google Scholar 

  • Ben Brahim E, Sfia M, Tangour M, Makhlouf R, Cribier B, Chatti S. Malignant eccrine spiradenoma: a new case report. J Cutan Pathol. 2010;37:478–81.

    Article  PubMed  Google Scholar 

  • Carlsten JR, Lewis MD, Saddler K, Reilly P, Pan T, Gnepp DR, Robinson-Bostom L. Spiradenocylindrocarcinoma: a malignant hybrid tumor. J Cutan Pathol. 2005;32:166–71.

    Article  PubMed  Google Scholar 

  • Chase DM, Basu T, Saffari B, Ries S, Berman ML. Malignant eccrine spiradenoma of the vulva: a case report and review of the literature. Int J Gynecol Cancer. 2006;16:1465–9.

    Article  CAS  PubMed  Google Scholar 

  • Dabska M. Malignant transformation of eccrine spiradenoma. Pol Med J. 1972;11:388.

    CAS  PubMed  Google Scholar 

  • Granter SR, Seeger K, Calonje E, Busam K, McKee PH. Malignant eccrine spiradenoma (spiradenocarcinoma): a clinicopathologic study of 12 cases. Am J Dermatopathol. 2000;22:97–103.

    Article  CAS  PubMed  Google Scholar 

  • Ishikawa M, Nakanishi Y, Yamazaki N, Yamamoto A. Malignant eccrine spiradenoma: a case report and review of the literature. Dermatol Surg. 2001;27:67–70.

    CAS  PubMed  Google Scholar 

  • Mirza I, Kloss R, Sieber SC. Malignant eccrine spiradenoma. Arch Pathol Lab Med. 2002;126:591–4.

    PubMed  Google Scholar 

  • Seyhan T, Borman H, Bal N. Malignant eccrine spiradenoma of the scalp. J Craniofac Surg. 2008;19:1608–12.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Valentina Caputo M.D. .

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Caputo, V., Rongioletti, F. (2015). Malignant Eccrine Spiradenoma. In: Rare Malignant Skin Tumors. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2023-5_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-2023-5_21

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-2022-8

  • Online ISBN: 978-1-4939-2023-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics